At a crossroads: coronavirus disease 2019 recovery and the risk of pulmonary vascular disease.

ABSTRACT:

Purpose of review

The coronavirus disease 2019 (COVID-19) pandemic has led to almost 3,000,000 deaths across 139 million people infected worldwide. Involvement of the pulmonary vasculature is considered a major driving force for morbidity and mortality. We set out to summarize current knowledge on the acute manifestations of pulmonary vascular disease (PVD) resulting from COVID-19 and prioritize long-term complications that may result in pulmonary hypertension (PH).

Recent findings

Acute COVID-19 infection can result in widespread involvement of the pulmonary vasculature, myocardial injury, evidence of persistent lung disease, and venous thromboembolism. Post COVID-19 survivors frequently report ongoing symptoms and may be at risk for the spectrum of PH, including group 1 pu

SUBMITTER: Cascino TM 

PROVIDER: S-EPMC8373709 | biostudies-literature | 2021 Sep

REPOSITORIES: biostudies-literature